Page last updated: 2024-09-05

sorafenib and sofosbuvir

sorafenib has been researched along with sofosbuvir in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (sofosbuvir)	Trials (sofosbuvir)	Recent Studies (post-2010) (sofosbuvir)
6,520	730	5,251	2,164	318	2,064

Protein Interaction Comparison

Protein	Taxonomy	sorafenib (IC50)	sofosbuvir (IC50)
Cytochrome P450 3A4	Homo sapiens (human)		8.4

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, B; Ghaffar, A; Jalal, F; Kamran, SK; Kiran, S; Munir, B; Oranab, S; Shehzadi, S; Zahoor, MK	1

Other Studies

1 other study(ies) available for sorafenib and sofosbuvir

Article	Year
Sorafenib tosylate, Ribavirn and Sofosbuvir combination therapy for HCV virus infected patients with decompensated liver cancer. Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:6(Suppleme Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis C; Humans; Liver Neoplasms; Male; Middle Aged; Ribavirin; Sofosbuvir; Sorafenib; Sustained Virologic Response; Treatment Outcome	2017

Article

Year

Sorafenib tosylate, Ribavirn and Sofosbuvir combination therapy for HCV virus infected patients with decompensated liver cancer.

Pakistan journal of pharmaceutical sciences, 2017, Volume: 30, Issue:6(Suppleme

Topics: Adult; Aged; Carcinoma, Hepatocellular; Drug Therapy, Combination; Female; Hepatitis C; Humans; Liver Neoplasms; Male; Middle Aged; Ribavirin; Sofosbuvir; Sorafenib; Sustained Virologic Response; Treatment Outcome

2017